You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:


Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Emcure Pharms Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?

EMCURE PHARMS LTD has twenty-nine approved drugs.

There is one tentative approval on EMCURE PHARMS LTD drugs.

Summary for Emcure Pharms Ltd
US Patents:0

Drugs and US Patents for Emcure Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 204090-001 Nov 26, 2013 DISCN No No   Start Trial   Start Trial
Emcure Pharms Ltd CIDOFOVIR cidofovir INJECTABLE;INJECTION 202501-001 Jul 26, 2012 AP RX No No   Start Trial   Start Trial
Emcure Pharms Ltd ADENOSINE adenosine SOLUTION;INTRAVENOUS 202313-001 Sep 15, 2014 DISCN No No   Start Trial   Start Trial
Emcure Pharms Ltd VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 202275-002 Oct 31, 2013 DISCN No No   Start Trial   Start Trial
Emcure Pharms Ltd LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 202590-001 Jan 24, 2013 DISCN No No   Start Trial   Start Trial
Emcure Pharms Ltd IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 200771-002 Feb 14, 2012 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.